4.1. Glucose, Insulin, and Lipid Profile
cardiovascular disease
CARDIOVASCULAR DISEASE
Reduced fasting glucose (−19.9 mg/dL) and insulin levels (−11.29 mg/dL) in response to 2–5 weeks of Comb-NMES are promising for promoting glucose homeostasis in acute SCI. This finding agrees with our previous work in individuals with long-standing SCI [LDL-cholesterol is a well-established cardiovascular disease risk factor for cardiovascular disease, with evidence from large-scale epidemiological and Mendelian randomization studies [